Phase 3 FIT Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease
Makerere University2,400 enrolled1 locationNCT05085171
Completed
Phase 3
Effects of testosterone and exercise (TEX) on fitness, physical activity and vascular health in men.
Overweight
Vascular healthFitness
Dr Bu Yeap80 enrolled1 locationACTRN12615000600549
Recruiting
Phase 3
A large-scale trial testing the intensity of CYTOreductive therapy to prevent cardiovascular events In patients with Polycythemia Vera (PV)
To assess the benefit/risk profile of cytoreductive therapy with phlebotomy and/or hydroxyurea (HU) aimed at maintaining hematocrit (HCT) < 45% Vs. maintaining HCT in the range of 45-50% in patients with PV treated at the best of recommended therapies (e.g., low dose of aspirin when indicated and adequated control of standard cardiovascular risk factors)
Consorzio Mario Negri Sud1,000 enrolled1 locationACTRN12609000046202
Terminated
Phase 3
Antidepressants, well-being and survival in advanced cancer. The ZEST Trial: A double-blind, placebo-controlled trial of Zoloft's Effects on Symptoms and survival Time in Advanced Cancer
People with advanced cancer in whom there is doubt about the benefits of treatment with antidepressants.
CTC440 enrolled1 locationACTRN12605000381684